- Home
- NMG vs AQST Comparison
NMG vs AQST Comparison
Compare NMG & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMG
- AQST
- Stock Information
- Founded
- NMG 2011
- AQST 2004
- Country
- NMG Canada
- AQST United States
- Employees
- NMG N/A
- AQST N/A
- Industry
- NMG Other Metals and Minerals
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- NMG Basic Materials
- AQST Health Care
- Exchange
- NMG Nasdaq
- AQST Nasdaq
- Market Cap
- NMG 251.2M
- AQST 272.9M
- IPO Year
- NMG 2017
- AQST 2018
- Fundamental
- Price
- NMG $1.62
- AQST $3.74
- Analyst Decision
- NMG Strong Buy
- AQST Strong Buy
- Analyst Count
- NMG 2
- AQST 6
- Target Price
- NMG $2.58
- AQST $10.67
- AVG Volume (30 Days)
- NMG 37.8K
- AQST 1.5M
- Earning Date
- NMG 08-13-2025
- AQST 08-05-2025
- Dividend Yield
- NMG N/A
- AQST N/A
- EPS Growth
- NMG N/A
- AQST N/A
- EPS
- NMG N/A
- AQST N/A
- Revenue
- NMG N/A
- AQST $54,228,000.00
- Revenue This Year
- NMG N/A
- AQST N/A
- Revenue Next Year
- NMG N/A
- AQST $45.71
- P/E Ratio
- NMG N/A
- AQST N/A
- Revenue Growth
- NMG N/A
- AQST 5.29
- 52 Week Low
- NMG $1.22
- AQST $2.12
- 52 Week High
- NMG $2.58
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- NMG 43.94
- AQST 68.54
- Support Level
- NMG $1.60
- AQST $3.13
- Resistance Level
- NMG $1.89
- AQST $3.33
- Average True Range (ATR)
- NMG 0.06
- AQST 0.22
- MACD
- NMG -0.01
- AQST 0.01
- Stochastic Oscillator
- NMG 28.57
- AQST 94.10
About NMG Nouveau Monde Graphite Inc.
Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The company currently operates in two segments: the Matawinie Mine Project and the Battery Material Plant project.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.